Intrinsiqs

Is Sight Sciences, Inc. overvalued?

Sight Sciences, Inc. (SGHT) — key valuation metrics and fundamentals.

No verdict
Price
$9.27
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$504.4M
Dividend yield
0.0%
Return on equity
-50.6%
Sector
Healthcare

See the full interactive analysis →

Fair value compares SGHT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.